BTG3 and myasthenia gravis: The other patient was found to be initially ANA positive prior to the development of MG manifestations and presented with severe generalized MG that required intubation and eventually resolved after treatment, which consisted of MMF, IVIG, methylprednisolone, pyridostigmine, cyclosporine, plasma exchange, and finally a course of rituximab.